Father and daughter

Hereditary cancer testing

Expand patients’ understanding of their risks

Approximately 5% to 10% of all cancers are thought to be caused by mutations in genes associated with hereditary cancer syndromes.1

As your patients learn more about genetic testing during family planning—and the conditions they may carry and pass on—they may have questions and concerns about certain cancers that may run in their families.

Hereditary Cancer Testing Options

This is why we provide hereditary cancer testing options—to extend the continuity of care beyond reproductive health, and ensure that your patients’ questions, concerns, and genetic testing for hereditary cancers can be managed by the same laboratory.

As with every family of tests we offer, Labcorp offers choice in testing options for hereditary cancer, with testing for identifying BRCA mutations associated with breast and ovarian cancer syndrome, as well as broader hereditary cancer panels for genes associated with many different types of cancer.

Educational Programs on Hereditary Cancer

In today’s medical environment, it can be challenging to find time to incorporate discussion on hereditary cancer risk assessment into a visit for each patient.

These brief programs are designed to provide the healthcare provider with information that may be used to develop a simple and straightforward screening strategy and help patients appreciate the impact hereditary cancer can have on their personal medical management and the health of their family.

Identifying Patients at Increased Risk

Why Genetic Testing Matters


  1. Family Cancer Syndromes. American Cancer Society website. https://www.cancer.org/cancer/cancer-causes/genetics/family-cancer-syndromes.html. Updated April 19, 2017. Accessed June 28, 2017.